Stabilizing apoA-I suppressed inflammation and improved the survivability of embryos and hyperlipidemic zebrafish by protecting them from CML-injected toxicity and anti-inflammatory activity. The gene discussed is APOA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.